hydralazine hydrochloride

Generic: hydralazine hydrochloride

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydralazine hydrochloride
Generic Name hydralazine hydrochloride
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydralazine hydrochloride 25 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-520
Product ID 31722-520_30381b85-deb3-bc70-e063-6294a90ad921
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040901
Listing Expiration 2026-12-31
Marketing Start 2010-01-01

Pharmacologic Class

Classes
arteriolar vasodilation [pe] arteriolar vasodilator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722520
Hyphenated Format 31722-520

Supplemental Identifiers

RxCUI
905199 905222 905225 905395
UPC
0331722519014 0331722521017 0331722522014 0331722520010
UNII
FD171B778Y

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydralazine hydrochloride (source: ndc)
Generic Name hydralazine hydrochloride (source: ndc)
Application Number ANDA040901 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (31722-520-01)
  • 500 TABLET in 1 BOTTLE (31722-520-05)
  • 1000 TABLET in 1 BOTTLE (31722-520-10)
source: ndc

Packages (3)

Ingredients (1)

hydralazine hydrochloride (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "30381b85-deb3-bc70-e063-6294a90ad921", "openfda": {"upc": ["0331722519014", "0331722521017", "0331722522014", "0331722520010"], "unii": ["FD171B778Y"], "rxcui": ["905199", "905222", "905225", "905395"], "spl_set_id": ["5da36930-d3da-4b5c-9e22-2b141bc01a9c"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-520-01)", "package_ndc": "31722-520-01", "marketing_start_date": "20100101"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-520-05)", "package_ndc": "31722-520-05", "marketing_start_date": "20100101"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (31722-520-10)", "package_ndc": "31722-520-10", "marketing_start_date": "20100101"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "31722-520_30381b85-deb3-bc70-e063-6294a90ad921", "dosage_form": "TABLET", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "31722-520", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "25 mg/1"}], "application_number": "ANDA040901", "marketing_category": "ANDA", "marketing_start_date": "20100101", "listing_expiration_date": "20261231"}